 | • レポートコード：GIR-2104Z06368 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ゲノムバイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ゲノムバイオマーカーの種類別市場規模（腫瘍、心血管疾患、神経疾患、その他）、用途別市場規模（診断研究所、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ゲノムバイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、Roche、Aepodia、Myriad Genetics、Eurofins Scientific、QIAGEN、Bio-Rad Laboratories、Genomic Health、Liquid Genomics、Epigenomics、AROS Applied Biotechnology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：腫瘍、心血管疾患、神経疾患、その他 ・用途別分析2016年-2026年：診断研究所、病院、その他 ・ゲノムバイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ゲノムバイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ゲノムバイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ゲノムバイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ゲノムバイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genomic Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genomic Biomarkers size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Genomic Biomarkers market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Genomic Biomarkers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oncology
Cardiovascular Diseases
Neurological Diseases
Others
Market segment by Application, can be divided into
Diagnostic and Research Laboratories
Hospitals
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Roche
Aepodia
Myriad Genetics
Eurofins Scientific
QIAGEN
Bio-Rad Laboratories
Genomic Health
Liquid Genomics
Epigenomics
AROS Applied Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Genomic Biomarkers
1.2 Classification of Genomic Biomarkers by Type
1.2.1 Overview: Global Genomic Biomarkers Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Genomic Biomarkers Revenue Market Share by Type in 2020
1.2.3 Oncology
1.2.4 Cardiovascular Diseases
1.2.5 Neurological Diseases
1.2.6 Others
1.3 Global Genomic Biomarkers Market by Application
1.3.1 Overview: Global Genomic Biomarkers Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Global Genomic Biomarkers Market Size & Forecast
1.5 Global Genomic Biomarkers Market Size and Forecast by Region
1.5.1 Global Genomic Biomarkers Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Genomic Biomarkers Market Size by Region, (2016-2021)
1.5.3 North America Genomic Biomarkers Market Size and Prospect (2016-2026)
1.5.4 Europe Genomic Biomarkers Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Genomic Biomarkers Market Size and Prospect (2016-2026)
1.5.6 South America Genomic Biomarkers Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Genomic Biomarkers Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genomic Biomarkers Market Drivers
1.6.2 Genomic Biomarkers Market Restraints
1.6.3 Genomic Biomarkers Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genomic Biomarkers Product and Solutions
2.1.4 Thermo Fisher Scientific Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Genomic Biomarkers Product and Solutions
2.2.4 Roche Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Aepodia
2.3.1 Aepodia Details
2.3.2 Aepodia Major Business
2.3.3 Aepodia Genomic Biomarkers Product and Solutions
2.3.4 Aepodia Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Aepodia Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Genomic Biomarkers Product and Solutions
2.4.4 Myriad Genetics Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Eurofins Scientific
2.5.1 Eurofins Scientific Details
2.5.2 Eurofins Scientific Major Business
2.5.3 Eurofins Scientific Genomic Biomarkers Product and Solutions
2.5.4 Eurofins Scientific Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eurofins Scientific Recent Developments and Future Plans
2.6 QIAGEN
2.6.1 QIAGEN Details
2.6.2 QIAGEN Major Business
2.6.3 QIAGEN Genomic Biomarkers Product and Solutions
2.6.4 QIAGEN Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 QIAGEN Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Genomic Biomarkers Product and Solutions
2.7.4 Bio-Rad Laboratories Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 Genomic Health
2.8.1 Genomic Health Details
2.8.2 Genomic Health Major Business
2.8.3 Genomic Health Genomic Biomarkers Product and Solutions
2.8.4 Genomic Health Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Genomic Health Recent Developments and Future Plans
2.9 Liquid Genomics
2.9.1 Liquid Genomics Details
2.9.2 Liquid Genomics Major Business
2.9.3 Liquid Genomics Genomic Biomarkers Product and Solutions
2.9.4 Liquid Genomics Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Liquid Genomics Recent Developments and Future Plans
2.10 Epigenomics
2.10.1 Epigenomics Details
2.10.2 Epigenomics Major Business
2.10.3 Epigenomics Genomic Biomarkers Product and Solutions
2.10.4 Epigenomics Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Epigenomics Recent Developments and Future Plans
2.11 AROS Applied Biotechnology
2.11.1 AROS Applied Biotechnology Details
2.11.2 AROS Applied Biotechnology Major Business
2.11.3 AROS Applied Biotechnology Genomic Biomarkers Product and Solutions
2.11.4 AROS Applied Biotechnology Genomic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AROS Applied Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genomic Biomarkers Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomic Biomarkers Players Market Share
3.2.2 Top 10 Genomic Biomarkers Players Market Share
3.2.3 Market Competition Trend
3.3 Genomic Biomarkers Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genomic Biomarkers Revenue and Market Share by Type (2016-2021)
4.2 Global Genomic Biomarkers Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Genomic Biomarkers Revenue Market Share by Application (2016-2021)
5.2 Genomic Biomarkers Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Genomic Biomarkers Revenue by Type (2016-2026)
6.2 North America Genomic Biomarkers Revenue by Application (2016-2026)
6.3 North America Genomic Biomarkers Market Size by Country
6.3.1 North America Genomic Biomarkers Revenue by Country (2016-2026)
6.3.2 United States Genomic Biomarkers Market Size and Forecast (2016-2026)
6.3.3 Canada Genomic Biomarkers Market Size and Forecast (2016-2026)
6.3.4 Mexico Genomic Biomarkers Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Genomic Biomarkers Revenue by Type (2016-2026)
7.2 Europe Genomic Biomarkers Revenue by Application (2016-2026)
7.3 Europe Genomic Biomarkers Market Size by Country
7.3.1 Europe Genomic Biomarkers Revenue by Country (2016-2026)
7.3.2 Germany Genomic Biomarkers Market Size and Forecast (2016-2026)
7.3.3 France Genomic Biomarkers Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Genomic Biomarkers Market Size and Forecast (2016-2026)
7.3.5 Russia Genomic Biomarkers Market Size and Forecast (2016-2026)
7.3.6 Italy Genomic Biomarkers Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genomic Biomarkers Revenue by Type (2016-2026)
8.2 Asia-Pacific Genomic Biomarkers Revenue by Application (2016-2026)
8.3 Asia-Pacific Genomic Biomarkers Market Size by Region
8.3.1 Asia-Pacific Genomic Biomarkers Revenue by Region (2016-2026)
8.3.2 China Genomic Biomarkers Market Size and Forecast (2016-2026)
8.3.3 Japan Genomic Biomarkers Market Size and Forecast (2016-2026)
8.3.4 South Korea Genomic Biomarkers Market Size and Forecast (2016-2026)
8.3.5 India Genomic Biomarkers Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Genomic Biomarkers Market Size and Forecast (2016-2026)
8.3.7 Australia Genomic Biomarkers Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Genomic Biomarkers Revenue by Type (2016-2026)
9.2 South America Genomic Biomarkers Revenue by Application (2016-2026)
9.3 South America Genomic Biomarkers Market Size by Country
9.3.1 South America Genomic Biomarkers Revenue by Country (2016-2026)
9.3.2 Brazil Genomic Biomarkers Market Size and Forecast (2016-2026)
9.3.3 Argentina Genomic Biomarkers Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genomic Biomarkers Revenue by Type (2016-2026)
10.2 Middle East & Africa Genomic Biomarkers Revenue by Application (2016-2026)
10.3 Middle East & Africa Genomic Biomarkers Market Size by Country
10.3.1 Middle East & Africa Genomic Biomarkers Revenue by Country (2016-2026)
10.3.2 Turkey Genomic Biomarkers Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Genomic Biomarkers Market Size and Forecast (2016-2026)
10.3.4 UAE Genomic Biomarkers Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Genomic Biomarkers Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Genomic Biomarkers Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Genomic Biomarkers Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Genomic Biomarkers Revenue (USD Million) by Region (2016-2021)
Table 5. Global Genomic Biomarkers Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Genomic Biomarkers Product and Solutions
Table 9. Thermo Fisher Scientific Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Genomic Biomarkers Product and Solutions
Table 13. Roche Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Aepodia Corporate Information, Head Office, and Major Competitors
Table 15. Aepodia Major Business
Table 16. Aepodia Genomic Biomarkers Product and Solutions
Table 17. Aepodia Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 19. Myriad Genetics Major Business
Table 20. Myriad Genetics Genomic Biomarkers Product and Solutions
Table 21. Myriad Genetics Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Eurofins Scientific Major Business
Table 24. Eurofins Scientific Genomic Biomarkers Product and Solutions
Table 25. Eurofins Scientific Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 27. QIAGEN Major Business
Table 28. QIAGEN Genomic Biomarkers Product and Solutions
Table 29. QIAGEN Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Genomic Biomarkers Product and Solutions
Table 33. Bio-Rad Laboratories Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 35. Genomic Health Major Business
Table 36. Genomic Health Genomic Biomarkers Product and Solutions
Table 37. Genomic Health Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Liquid Genomics Corporate Information, Head Office, and Major Competitors
Table 39. Liquid Genomics Major Business
Table 40. Liquid Genomics Genomic Biomarkers Product and Solutions
Table 41. Liquid Genomics Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Epigenomics Corporate Information, Head Office, and Major Competitors
Table 43. Epigenomics Major Business
Table 44. Epigenomics Genomic Biomarkers Product and Solutions
Table 45. Epigenomics Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AROS Applied Biotechnology Corporate Information, Head Office, and Major Competitors
Table 47. AROS Applied Biotechnology Major Business
Table 48. AROS Applied Biotechnology Genomic Biomarkers Product and Solutions
Table 49. AROS Applied Biotechnology Genomic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Genomic Biomarkers Revenue (USD Million) by Players (2019-2021)
Table 51. Global Genomic Biomarkers Revenue Share by Players (2019-2021)
Table 52. Breakdown of Genomic Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Genomic Biomarkers Players Head Office, Products and Services Provided
Table 54. Genomic Biomarkers Mergers & Acquisitions in the Past Five Years
Table 55. Genomic Biomarkers New Entrants and Expansion Plans
Table 56. Global Genomic Biomarkers Revenue (USD Million) by Type (2016-2021)
Table 57. Global Genomic Biomarkers Revenue Share by Type (2016-2021)
Table 58. Global Genomic Biomarkers Revenue Forecast by Type (2021-2026)
Table 59. Global Genomic Biomarkers Revenue by Application (2016-2021)
Table 60. Global Genomic Biomarkers Revenue Forecast by Application (2021-2026)
Table 61. North America Genomic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Genomic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Genomic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Genomic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Genomic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Genomic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Genomic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Genomic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Genomic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Genomic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Genomic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Genomic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Genomic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Genomic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Genomic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Genomic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Genomic Biomarkers Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Genomic Biomarkers Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Genomic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Genomic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Genomic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Genomic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Genomic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Genomic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Genomic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Genomic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Genomic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Genomic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Genomic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Genomic Biomarkers Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Genomic Biomarkers Picture
Figure 2. Global Genomic Biomarkers Revenue Market Share by Type in 2020
Figure 3. Oncology
Figure 4. Cardiovascular Diseases
Figure 5. Neurological Diseases
Figure 6. Others
Figure 7. Genomic Biomarkers Revenue Market Share by Application in 2020
Figure 8. Diagnostic and Research Laboratories Picture
Figure 9. Hospitals Picture
Figure 10. Others Picture
Figure 11. Global Genomic Biomarkers Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Genomic Biomarkers Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Genomic Biomarkers Revenue Market Share by Region (2016-2026)
Figure 14. Global Genomic Biomarkers Revenue Market Share by Region in 2020
Figure 15. North America Genomic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Genomic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Genomic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Genomic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Genomic Biomarkers Market Drivers
Figure 20. Genomic Biomarkers Market Restraints
Figure 21. Genomic Biomarkers Market Trends
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. Aepodia Recent Developments and Future Plans
Figure 25. Myriad Genetics Recent Developments and Future Plans
Figure 26. Eurofins Scientific Recent Developments and Future Plans
Figure 27. QIAGEN Recent Developments and Future Plans
Figure 28. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 29. Genomic Health Recent Developments and Future Plans
Figure 30. Liquid Genomics Recent Developments and Future Plans
Figure 31. Epigenomics Recent Developments and Future Plans
Figure 32. AROS Applied Biotechnology Recent Developments and Future Plans
Figure 34. Global Genomic Biomarkers Revenue Share by Players in 2020
Figure 35. Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Genomic Biomarkers Revenue Market Share in 2020
Figure 37. Global Top 10 Players Genomic Biomarkers Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Genomic Biomarkers Revenue Share by Type in 2020
Figure 40. Global Genomic Biomarkers Market Share Forecast by Type (2021-2026)
Figure 41. Global Genomic Biomarkers Revenue Share by Application in 2020
Figure 42. Global Genomic Biomarkers Market Share Forecast by Application (2021-2026)
Figure 43. North America Genomic Biomarkers Sales Market Share by Type (2016-2026)
Figure 44. North America Genomic Biomarkers Sales Market Share by Application (2016-2026)
Figure 45. North America Genomic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 46. United States Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Genomic Biomarkers Sales Market Share by Type (2016-2026)
Figure 50. Europe Genomic Biomarkers Sales Market Share by Application (2016-2026)
Figure 51. Europe Genomic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 52. Germany Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Genomic Biomarkers Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Genomic Biomarkers Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Genomic Biomarkers Revenue Market Share by Region (2016-2026)
Figure 60. China Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Genomic Biomarkers Sales Market Share by Type (2016-2026)
Figure 67. South America Genomic Biomarkers Sales Market Share by Application (2016-2026)
Figure 68. South America Genomic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Genomic Biomarkers Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Genomic Biomarkers Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Genomic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Genomic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のゲノミクスバイオマーカー市場規模・現状・予測（2021年-2027年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…- 世界の予測バイオマーカー市場規模・現状・予測（2021年-2027年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- 世界の遺伝子医療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genomic Medicine Market The global Genomic Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のがんバイオマーカー検出市場規模・現状・予測（2021年-2027年） Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells. Market Analysis and Insights: Global Cancer Biomarkers Detection Market The global Cancer Biomarkers Detection market size is projected to reach US$ XX million by 2027, from US$ XX …
- 世界のバイオマーカー市場規模・現状・予測（2021年-2027年） In biological system, it means to calculate the whole number by marking part of individuals. North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share o…